2022
Questioning Our Approach to Hyperbilirubinemia.
Grossman MR, Berkwitt AK, Osborn RR. Questioning Our Approach to Hyperbilirubinemia. Hospital Pediatrics 2022, 12: e137-e139. PMID: 35362053, DOI: 10.1542/hpeds.2021-006441.Peer-Reviewed Original Research
2015
The Utility of Inpatient Rebound Bilirubin Levels in Infants Readmitted After Birth Hospitalization for Hyperbilirubinemia
Berkwitt A, Osborn R, Grossman M. The Utility of Inpatient Rebound Bilirubin Levels in Infants Readmitted After Birth Hospitalization for Hyperbilirubinemia. Hospital Pediatrics 2015, 5: 74-78. PMID: 25646199, DOI: 10.1542/hpeds.2014-0074.Peer-Reviewed Original ResearchConceptsBilirubin levelsLength of stayBirth hospitalizationIndirect hyperbilirubinemiaRebound groupDiscontinuation of phototherapyRetrospective cohort studyManagement of infantsCharacteristics of childrenCohort studySecondary outcomesHospital readmissionPrimary outcomePatient populationSubgroup analysisClinical utilityPatientsInfantsHospitalizationHyperbilirubinemiaPhototherapyReadmissionStayDlPresent study